@article{article, title  = {{Impact of Donor-Derived CD34+ Infused Cell Dose on Outcomes of Patients Undergoing Allo-HCT Following Reduced Intensity Regimen for Myelofibrosis:a Study from the Chronic Malignancies Working Party of the EBMT}},

 publisher = {{American Society of Hematology}},

 url = {{}},

 year = {{2019}},

 month = {{11}},

 author = {{Czerw T and Malpassuti V and Iacobelli S and Koster L and Kröger N and Robin M and Maertens J and Chevallier P and Mielke S and Poire X and Snowden JA et al}},

 doi = {{10.1182/blood-2019-123827}},

 volume = {{134}},

 journal = {{Blood}},

 issue = {{Supplement_1}},

 pages = {{3338-3338}},

 note = {{Accessed on 2024/12/22}}}